글로벌 임상 시험 소모품 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

임상 시험 소모품 시장 분석

임상 시험 소모품 시장은 임상 시험의 증가와 효율적인 연구 프로세스에 대한 필요성에 힘입어 강력한 성장을 경험하고 있습니다. 제약 회사와 계약 연구 기관(CRO)이 운영을 확장함에 따라 주사기 , 바이알, 샘플 수집 키트와 같은 소모품에 대한 수요가 증가하고 있습니다. 주요 추세는 환자 중심 시험으로의 전환으로, 참가자 참여와 데이터 수집을 개선하기 위해 혁신적인 소모품 솔루션이 필요합니다. 또한 자동화 및 디지털 솔루션을 포함한 기술의 발전으로 시험 프로세스가 간소화되고 데이터 정확도가 향상되고 있습니다. 스마트 라벨링 및 추적 시스템의 도입과 같은 최근의 개발은 공급망 관리를 더욱 최적화하여 시험 장소가 잘 갖춰져 있고 규제 표준을 준수하도록 보장합니다. 이러한 역동적인 환경은 임상 시험 소모품 부문의 이해 관계자에게 상당한 기회를 제공합니다.

임상 시험 소모품 시장 규모

글로벌 임상 시험 소모품 시장 규모는 2023년에 22억 3천만 달러로 평가되었으며, 2031년까지 42억 5천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.40%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

임상 시험 소모품 시장 동향

“ 장시간 작용 주사제에 대한 선호도 증가”

임상 시험 소모품 시장은 몇 가지 주요 트렌드에 의해 주도되어 빠르게 진화하고 있습니다. 중요한 트렌드 중 하나는 디지털 도구와 원격 모니터링을 활용하여 환자가 집에서 참여할 수 있도록 하는 분산형 임상 시험(DCT)에 대한 관심이 높아지고 있다는 것입니다. 이 접근 방식은 환자 참여를 강화하고, 데이터 수집을 간소화하며, 기존 시험과 관련된 물류적 어려움을 줄여줍니다. 또한, 개인화된 의학에 대한 수요가 증가함에 따라 특정 환자의 요구에 맞는 맞춤형 소모품이 요구되고 있습니다. 최근 개발에는 RFID 추적 및 블록체인과 같은 첨단 기술을 통합하여 공급망 투명성을 강화하고 시험 자료의 무결성을 보장하는 것이 포함됩니다. 이러한 혁신은 임상 시험 환경을 재편하고 연구자와 스폰서에게 보다 효율적이고 규정을 준수하는 솔루션을 제공합니다.

보고서 범위 및 임상 시험 소모품 시장 세분화 

Clinical Trial Consumables Market Definition

Clinical trial consumables refer to the various materials and supplies used throughout the clinical research process to support the development and testing of new drugs, therapies, or medical devices. These consumables include items such as syringes, vials, tubes, labels, specimen collection kits, and personal protective equipment. They play a crucial role in ensuring the proper conduct of clinical trials, maintaining sample integrity, and facilitating the collection and analysis of data. As clinical trials become more complex, the demand for innovative and high-quality consumables continues to grow, reflecting the need for efficiency, safety, and regulatory compliance in the research process.

Clinical Trial Consumables Market Dynamics

Drivers

• Growing Demand for Consumables in Clinical Trials

The increase in global clinical trials, especially in emerging markets, significantly drives the demand for various consumables essential for different phases of research. As pharmaceutical companies and research organizations seek to develop new therapies and treatments, they are increasingly turning to regions such as Asia and Latin America, where regulatory processes are evolving and patient populations are diverse. This expansion necessitates a wide range of consumables, including laboratory supplies, reagents, and medical devices, to ensure the trials run smoothly. Furthermore, the growing focus on personalized medicine and innovative study designs, such as adaptive trials, requires specialized consumables tailored to meet specific research needs, ultimately driving the market growth.

• Innovations Driving Clinical Trial Consumables Efficiency

The advancements in materials and manufacturing processes are a key driver in enhancing the efficiency and reliability of clinical trial consumables. Advanced materials, such as biodegradable plastics and high-strength composites, are being developed to meet stringent regulatory standards while minimizing environmental impact. Techniques such as 3D printing enable rapid prototyping and production of custom consumables tailored to specific trial requirements. These innovations not only reduce lead times but also improve the quality and performance of the products used in clinical research. Consequently, researchers are increasingly attracted to these solutions, recognizing their potential to streamline trials and ensure more accurate outcomes, ultimately accelerating drug development and market entry.

Opportunities

• Innovations in Clinical Trial Methodologies

Innovations in clinical trial methodologies, particularly decentralized trials and remote monitoring, present significant opportunities for growth in the clinical trial consumables market. Decentralized trials leverage digital technologies to conduct studies outside traditional clinical settings, creating a demand for new consumables such as home diagnostic kits, telehealth platforms, and mobile health devices. Remote monitoring enhances patient engagement and data collection, requiring supplies that facilitate real-time health tracking, such as wearable sensors and mobile applications. These advancements not only improve patient accessibility and convenience but also generate opportunities for companies to develop and supply innovative consumables that ensure data integrity and compliance. Thus, the evolving methodologies represent a promising avenue for market expansion.

• Demand for Specialized Consumables in Personalized Medicine

As personalized medicine gains traction, the demand for specialized consumables tailored to specific treatments is increasingly vital. This approach focuses on customizing healthcare based on individual patient characteristics, including genetics, lifestyle, and environment, necessitating the development of targeted consumables. These may include bespoke diagnostic kits, biomarkers for patient stratification, and specialized delivery systems for therapies. In addition, as treatment regimens become more complex, the need for consumables that support precision dosing and monitoring becomes critical. This shift not only enhances treatment efficacy but also creates opportunities for manufacturers to innovate and diversify their product offerings, positioning themselves at the forefront of the personalized medicine revolution and meeting the unique needs of healthcare providers and patients asuch as.

Restraints/Challenges

• Supply Chain Challenges in Clinical Trial Consumables

Global supply chain issues pose a significant challenge for the clinical trial consumables market, leading to shortages and delays in availability. Events such as pandemics, natural disasters, and geopolitical tensions disrupt transportation networks and manufacturing processes, creating critical bottlenecks. For example, during the COVID-19 pandemic, many suppliers faced unprecedented challenges in sourcing raw materials and shipping finished products. These disruptions can result in delayed clinical trials, increased costs, and potential loss of data integrity. Furthermore, reliance on a limited number of suppliers for specialized consumables exacerbates these vulnerabilities.

• Budget Constraints in Clinical Trials

Limited budgets for clinical trials serve as a significant restraint on the clinical trial consumables market, constraining spending on essential materials. When funding is tight, organizations often prioritize critical trial components, which can lead to reduced investment in consumables and negatively affect the quality and variety of materials used. This may result in the selection of lower-quality products or insufficient supplies, compromising data integrity and overall trial outcomes. In addition, budget constraints can hinder the incorporation of innovative consumables that enhance trial efficiency or patient engagement. Ultimately, the lack of adequate resources restricts clinical trials' ability to achieve their objectives, impacting the development of new therapies and treatments.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Clinical Trial Consumables Market Scope

The market is segmented on the basis of service, phase, therapeutic area, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Service

• Manufacturing
• Packaging and Labeling
• Logistics and Distribution

  Phase

• Phase I
• Phase II
• Phase III

Therapeutic Area

• Oncology
• CNS and Mental Disorders
• Cardiovascular Diseases
• Infectious Diseases
• Respiratory Diseases
• Blood Disorders
• Dermatology
• Others

End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Medical Devices Companies

Distribution Channel

• Dermatology Clinics
• Hospitals
• Pharmacies
• Others

 Clinical Trial Consumables Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, service, phase, therapeutic area, end user, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the clinical trial consumables market, driven by an increasing number of registered clinical trials. In addition, rising investments in research and development are expected to further enhance market growth in the region throughout the forecast period. This combination of factors positions North America as a key player in the clinical trial landscape.

Asia-Pacific region is expected to experience substantial growth in the clinical trial consumables market, driven by an increasing number of healthcare companies conducting clinical trials. In addition, supportive government regulations and the availability of cost-effective products are such asly to further boost market expansion in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Clinical Trial Consumables Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Clinical Trial Consumables Market Leaders Operating in the Market Are:

• Almac Group (U.K.)
• Catalent, Inc. (U.S.)
• Parexel International (MA) Corporation (U.S.)
• Agilent Technology (U.S.)
• Thermo Fisher Scientific, Inc. (U.S.)
• SHARP CORPORATION (U.K.)
• Biocair (U.K.)
• Movianto (U.K.)
• KLIFO (Denmark)
• Bellco Glass (U.S.)
• Crystalgen, Inc. (U.S.)
• Camlab Ltd (U.K.)
• Reagecon Diagnostics Ltd. (Ireland)
• Sartorius AG (Germany)
• Spectrum Chemical (U.S.)
• Inizio (Ireland)
• Piramal Enterprises Ltd. (India)
• VITLAB GmbH (Germany)

임상 시험 소모품 시장의 최신 동향

• 2023년 7월, Almac Sciences는 영국 Craigavon에 있는 Almac Group의 글로벌 본사에 맞춤형 GMP 창고 및 배송 허브를 공개했습니다. 이 새로운 시설은 개발부터 상용화까지 활성 제약 성분과 관련된 전체 제조 및 실험실 활동을 지원하도록 설계되었습니다.
• 2023년 2월, Catalent는 싱가포르에 있는 임상 공급 시설을 220만 달러에 확장했다고 발표했습니다. 이 개선으로 시설 면적이 31,000제곱피트로 늘어나 초저온(ULT) 보관을 위해 특별히 설계된 35개의 새로운 냉동고를 설치할 수 있었습니다. 이 전략적 확장은 용량을 늘릴 뿐만 아니라 정확한 보관 조건이 필요한 임상 시험 재료에 대한 증가하는 수요를 충족할 수 있는 Catalent의 역량을 강화합니다.

SKU-20251